retatrutide dosing bodybuilding Dosage Guide 2026: Phase 3 TRIUMPH Data Retatrutide and bodybuilding: Can it

Despite the name, Peaka GLP-1 does not contain synthetic GLP-1 or any GLP-1 receptor agonist

That said, some researchers find that injecting on a completely empty stomach intensifies the initial nausea

Retatrutide is still investigational and not approved by any regulator as of April 2026, so everything below is presented as clinical-trial data, not as medical guidance

Patients often experience enhanced tolerability through the gradual therapeutic introduction, with a notably reduced incidence of gastrointestinal side effects

And research has shown promise that the drugs may aid a range of conditions

Fiber is a particular concern given that the keto diet restricts many fiber-rich foods such as whole grains, fruits, vegetables, and beans